Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

NCT01227135 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: hydroxychloroquine
DRUG: imatinib mesylate
GENETIC: cytogenetic analysis
GENETIC: polymerase chain reaction
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Lynn McMahon

Collaborators

[object Object]
[object Object]